Previous 10 | Next 10 |
(NewsDirect) By David Willey, Benzinga Learn more about NanoViricides, Inc. by gaining access to the latest research report Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates...
--News Direct-- By David Willey, Benzinga Learn more about NanoViricides, Inc. by gaining access to the latest research report Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high ra...
(NewsDirect) By Ernest Dela Aglanu, Benzinga With the COVID pandemic still ongoing, having claimed more than 6.8 million lives from about 758 million cases and crippling the global economy, there are several reasons why drug research and development related to the COVID virus rema...
(NewsDirect) By Ernest Dela Aglanu, Benzinga Read the latest report on NanoViricides, Inc (NYSE : NNVC) here . The Centers for Disease Control (CDC) remains vigilant against the increased spread or return of COVID because there are still close to 20,000 hospitalizations ...
--News Direct-- By Ernest Dela Aglanu, Benzinga Read the latest report on NanoViricides, Inc (NYSE : NNVC) here . The Centers for Disease Control (CDC) remains vigilant against the increased spread or return of COVID because there are still close to 20,000 hospitalizations...
SHELTON, CT / ACCESSWIRE / February 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending December 31, 2022 with the Securities and Exchange Commission (SEC) on Tuesday, February 14, ...
SHELTON, CT / ACCESSWIRE / January 4, 2023 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk in person at the Biotech Showcase™ 2023 Conference in San Fransisco on Monday, January 9th at 10:30pm PT....
SHELTON, CT / ACCESSWIRE / December 5, 2022 / NanoViricides, Inc. (NYSE Amer. NNVC ) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET. The presentation...
Palm Beach, FL – November 15, 2022 – FinancialNewsMedia.com News Commentary – Chronic obstructive pulmonary disease is a chronic lung disease that prevents airflow from the lungs. The rising incidence of COPD is one factor driving expansion in the COPD drug ...
NanoViricides ( NYSE: NNVC ) FQ1 net loss narrowed to -$1.57M, compared to -$2.61M in the prior year period. The company said that it has sufficient funds to complete initial human clinical trials of its lead drug candidate NV-CoV-2 to treat COVID-19 and long COVID. ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
20.73%Change Percent:
NanoViricides Inc. Company Name:
NNVC Stock Symbol:
NYSE Market:
NanoViricides Inc. Website:
SHELTON, CT / ACCESSWIRE / June 20, 2024 / NanoViricides, Inc. (NYSE AmerIcan.: NNVC ) (the "Company"), a clinical stage company and global leader in broad-spectrum antiviral nanomedicines, reports that the ultra-broad-spectrum antiviral NV-387, a clinical Phase II stage drug candidate, was foun...
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results. AMMO reported a fourth-quarter profi...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 1.8% to $131.88 on volume of 307,014,213 shares SRIVARU Holding Limited (SVMH) rose 49.2% to $0.2275 on volume of 274,465,266 shares Nauticus Robotics Inc. (KITT) rose 19.6% to $0.192 on volume of 161,46...